CRRTF
Price:
$0.5587
Market Cap:
$14.71M
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermat...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2016-04-11
Stock Exchange
OTC
Ticker
CRRTF
According to Crescita Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -42.49. This represents a change of 80.96% compared to the average of -0.05 of the last 4 quarters.
The mean historical PE Ratio of Crescita Therapeutics, Inc. over the last ten years is 29.80. The current -42.49 PE Ratio has changed -14355.91% with respect to the historical average. Over the past ten years (40 quarters), CRRTF's PE Ratio was at its highest in in the March 2019 quarter at 87.50. The PE Ratio was at its lowest in in the December 2024 quarter at -17.06.
Average
29.80
Median
-0.79
Minimum
-97.96
Maximum
388.89
Discovering the peaks and valleys of Crescita Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.60%
Maximum Annual PE Ratio = 388.89
Minimum Annual Increase = -673.74%
Minimum Annual PE Ratio = -97.96
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -97.96 | 2.26% |
| 2024 | -4.14 | -17.14% |
| 2023 | -5.00 | -131.59% |
| 2022 | 15.83 | -229.54% |
| 2021 | -12.22 | -103.14% |
| 2020 | 388.89 | 3.60% |
| 2019 | 10.50 | 183.05% |
| 2018 | 3.71 | -673.74% |
| 2017 | -0.65 | -30.22% |
| 2016 | -0.93 | -14.64% |
The current PE Ratio of Crescita Therapeutics, Inc. (CRRTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-35.70
5-year avg
-20.70
10-year avg
29.80
Crescita Therapeutics, Inc.’s PE Ratio is less than Ayurcann Holdings Corp. (-0.45), less than Delivra Health Brands Inc. (-2.93), less than Ayr Wellness Inc. (-0.03), less than Christina Lake Cannabis Corp. (-1.62), less than CV Sciences, Inc. (-3.02), less than Bright Green Corporation (-0.01), less than CanaFarma Hemp Products Corp. (-0.00), less than Healthy Extracts Inc. (-10.78), less than Univec, Inc. (15.50), less than Tristar Wellness Solutions Inc. (-10.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.45 | $58.41K | |
| -2.93 | $2.21M | |
| -0.03 | $432.06K | |
| -1.62 | $4.86M | |
| -3.02 | $4.94M | |
| -0.01 | $7.26M | |
| -0.00 | $19.56K | |
| -10.78 | $4.20M | |
| 15.50 | $7.82M | |
| -10.00 | $56.00K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crescita Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Crescita Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Crescita Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Crescita Therapeutics, Inc. (CRRTF)?
What is the highest PE Ratio for Crescita Therapeutics, Inc. (CRRTF)?
What is the 3-year average PE Ratio for Crescita Therapeutics, Inc. (CRRTF)?
What is the 5-year average PE Ratio for Crescita Therapeutics, Inc. (CRRTF)?
How does the current PE Ratio for Crescita Therapeutics, Inc. (CRRTF) compare to its historical average?